The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Tiopronin it is mainly used to improve liver function, fatty liver, alcoholic liver, drug-induced liver injury and detoxification of heavy metals, reduce the adverse reactions of radiotherapy and chemotherapy of all kinds of acute and chronic hepatitis
The global Tiopronin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tiopronin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tiopronin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tiopronin in Fatty liver Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tiopronin include Henan Xinyi Pharmaceutical Group, Changzhou Yabang Pharmaceutical Co. Ltd, Jiangsu Desano Pharmaceutical Co. Ltd, Hangzhou Minsheng Pharmaceutical Co. Ltd, Wuhan Yuanda Pharmaceutical Group, Shanghai Kaibao Pharmaceutical Co., Ltd., Sinopharm Guorui Pharmaceutical Co. Ltd, AdvaCare and Clinigen Direct, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tiopronin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tiopronin.
Report Scope
The Tiopronin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tiopronin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tiopronin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Henan Xinyi Pharmaceutical Group
Changzhou Yabang Pharmaceutical Co. Ltd
Jiangsu Desano Pharmaceutical Co. Ltd
Hangzhou Minsheng Pharmaceutical Co. Ltd
Wuhan Yuanda Pharmaceutical Group
Shanghai Kaibao Pharmaceutical Co., Ltd.
Sinopharm Guorui Pharmaceutical Co. Ltd
AdvaCare
Clinigen Direct
Segment by Type
Injection
Tablet
Capsule
Segment by Application
Fatty liver Disease
Early Senile Cataract
Eczema
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tiopronin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tiopronin it is mainly used to improve liver function, fatty liver, alcoholic liver, drug-induced liver injury and detoxification of heavy metals, reduce the adverse reactions of radiotherapy and chemotherapy of all kinds of acute and chronic hepatitis
The global Tiopronin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tiopronin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tiopronin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tiopronin in Fatty liver Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tiopronin include Henan Xinyi Pharmaceutical Group, Changzhou Yabang Pharmaceutical Co. Ltd, Jiangsu Desano Pharmaceutical Co. Ltd, Hangzhou Minsheng Pharmaceutical Co. Ltd, Wuhan Yuanda Pharmaceutical Group, Shanghai Kaibao Pharmaceutical Co., Ltd., Sinopharm Guorui Pharmaceutical Co. Ltd, AdvaCare and Clinigen Direct, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tiopronin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tiopronin.
Report Scope
The Tiopronin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tiopronin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tiopronin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Henan Xinyi Pharmaceutical Group
Changzhou Yabang Pharmaceutical Co. Ltd
Jiangsu Desano Pharmaceutical Co. Ltd
Hangzhou Minsheng Pharmaceutical Co. Ltd
Wuhan Yuanda Pharmaceutical Group
Shanghai Kaibao Pharmaceutical Co., Ltd.
Sinopharm Guorui Pharmaceutical Co. Ltd
AdvaCare
Clinigen Direct
Segment by Type
Injection
Tablet
Capsule
Segment by Application
Fatty liver Disease
Early Senile Cataract
Eczema
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tiopronin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tiopronin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Tablet
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Tiopronin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Fatty liver Disease
1.3.3 Early Senile Cataract
1.3.4 Eczema
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tiopronin Market Perspective (2019-2030)
2.2 Tiopronin Growth Trends by Region
2.2.1 Global Tiopronin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tiopronin Historic Market Size by Region (2019-2024)
2.2.3 Tiopronin Forecasted Market Size by Region (2025-2030)
2.3 Tiopronin Market Dynamics
2.3.1 Tiopronin Industry Trends
2.3.2 Tiopronin Market Drivers
2.3.3 Tiopronin Market Challenges
2.3.4 Tiopronin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tiopronin Players by Revenue
3.1.1 Global Top Tiopronin Players by Revenue (2019-2024)
3.1.2 Global Tiopronin Revenue Market Share by Players (2019-2024)
3.2 Global Tiopronin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tiopronin Revenue
3.4 Global Tiopronin Market Concentration Ratio
3.4.1 Global Tiopronin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tiopronin Revenue in 2023
3.5 Tiopronin Key Players Head office and Area Served
3.6 Key Players Tiopronin Product Solution and Service
3.7 Date of Enter into Tiopronin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tiopronin Breakdown Data by Type
4.1 Global Tiopronin Historic Market Size by Type (2019-2024)
4.2 Global Tiopronin Forecasted Market Size by Type (2025-2030)
5 Tiopronin Breakdown Data by Application
5.1 Global Tiopronin Historic Market Size by Application (2019-2024)
5.2 Global Tiopronin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tiopronin Market Size (2019-2030)
6.2 North America Tiopronin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tiopronin Market Size by Country (2019-2024)
6.4 North America Tiopronin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tiopronin Market Size (2019-2030)
7.2 Europe Tiopronin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tiopronin Market Size by Country (2019-2024)
7.4 Europe Tiopronin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tiopronin Market Size (2019-2030)
8.2 Asia-Pacific Tiopronin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tiopronin Market Size by Region (2019-2024)
8.4 Asia-Pacific Tiopronin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tiopronin Market Size (2019-2030)
9.2 Latin America Tiopronin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tiopronin Market Size by Country (2019-2024)
9.4 Latin America Tiopronin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tiopronin Market Size (2019-2030)
10.2 Middle East & Africa Tiopronin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tiopronin Market Size by Country (2019-2024)
10.4 Middle East & Africa Tiopronin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Henan Xinyi Pharmaceutical Group
11.1.1 Henan Xinyi Pharmaceutical Group Company Detail
11.1.2 Henan Xinyi Pharmaceutical Group Business Overview
11.1.3 Henan Xinyi Pharmaceutical Group Tiopronin Introduction
11.1.4 Henan Xinyi Pharmaceutical Group Revenue in Tiopronin Business (2019-2024)
11.1.5 Henan Xinyi Pharmaceutical Group Recent Development
11.2 Changzhou Yabang Pharmaceutical Co. Ltd
11.2.1 Changzhou Yabang Pharmaceutical Co. Ltd Company Detail
11.2.2 Changzhou Yabang Pharmaceutical Co. Ltd Business Overview
11.2.3 Changzhou Yabang Pharmaceutical Co. Ltd Tiopronin Introduction
11.2.4 Changzhou Yabang Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024)
11.2.5 Changzhou Yabang Pharmaceutical Co. Ltd Recent Development
11.3 Jiangsu Desano Pharmaceutical Co. Ltd
11.3.1 Jiangsu Desano Pharmaceutical Co. Ltd Company Detail
11.3.2 Jiangsu Desano Pharmaceutical Co. Ltd Business Overview
11.3.3 Jiangsu Desano Pharmaceutical Co. Ltd Tiopronin Introduction
11.3.4 Jiangsu Desano Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024)
11.3.5 Jiangsu Desano Pharmaceutical Co. Ltd Recent Development
11.4 Hangzhou Minsheng Pharmaceutical Co. Ltd
11.4.1 Hangzhou Minsheng Pharmaceutical Co. Ltd Company Detail
11.4.2 Hangzhou Minsheng Pharmaceutical Co. Ltd Business Overview
11.4.3 Hangzhou Minsheng Pharmaceutical Co. Ltd Tiopronin Introduction
11.4.4 Hangzhou Minsheng Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024)
11.4.5 Hangzhou Minsheng Pharmaceutical Co. Ltd Recent Development
11.5 Wuhan Yuanda Pharmaceutical Group
11.5.1 Wuhan Yuanda Pharmaceutical Group Company Detail
11.5.2 Wuhan Yuanda Pharmaceutical Group Business Overview
11.5.3 Wuhan Yuanda Pharmaceutical Group Tiopronin Introduction
11.5.4 Wuhan Yuanda Pharmaceutical Group Revenue in Tiopronin Business (2019-2024)
11.5.5 Wuhan Yuanda Pharmaceutical Group Recent Development
11.6 Shanghai Kaibao Pharmaceutical Co., Ltd.
11.6.1 Shanghai Kaibao Pharmaceutical Co., Ltd. Company Detail
11.6.2 Shanghai Kaibao Pharmaceutical Co., Ltd. Business Overview
11.6.3 Shanghai Kaibao Pharmaceutical Co., Ltd. Tiopronin Introduction
11.6.4 Shanghai Kaibao Pharmaceutical Co., Ltd. Revenue in Tiopronin Business (2019-2024)
11.6.5 Shanghai Kaibao Pharmaceutical Co., Ltd. Recent Development
11.7 Sinopharm Guorui Pharmaceutical Co. Ltd
11.7.1 Sinopharm Guorui Pharmaceutical Co. Ltd Company Detail
11.7.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
11.7.3 Sinopharm Guorui Pharmaceutical Co. Ltd Tiopronin Introduction
11.7.4 Sinopharm Guorui Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024)
11.7.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Development
11.8 AdvaCare
11.8.1 AdvaCare Company Detail
11.8.2 AdvaCare Business Overview
11.8.3 AdvaCare Tiopronin Introduction
11.8.4 AdvaCare Revenue in Tiopronin Business (2019-2024)
11.8.5 AdvaCare Recent Development
11.9 Clinigen Direct
11.9.1 Clinigen Direct Company Detail
11.9.2 Clinigen Direct Business Overview
11.9.3 Clinigen Direct Tiopronin Introduction
11.9.4 Clinigen Direct Revenue in Tiopronin Business (2019-2024)
11.9.5 Clinigen Direct Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Tiopronin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Tablet
Table 4. Key Players of Capsule
Table 5. Global Tiopronin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tiopronin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Tiopronin Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Tiopronin Market Share by Region (2019-2024)
Table 9. Global Tiopronin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Tiopronin Market Share by Region (2025-2030)
Table 11. Tiopronin Market Trends
Table 12. Tiopronin Market Drivers
Table 13. Tiopronin Market Challenges
Table 14. Tiopronin Market Restraints
Table 15. Global Tiopronin Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Tiopronin Market Share by Players (2019-2024)
Table 17. Global Top Tiopronin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tiopronin as of 2023)
Table 18. Ranking of Global Top Tiopronin Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Tiopronin Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tiopronin Product Solution and Service
Table 22. Date of Enter into Tiopronin Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tiopronin Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Tiopronin Revenue Market Share by Type (2019-2024)
Table 26. Global Tiopronin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Tiopronin Revenue Market Share by Type (2025-2030)
Table 28. Global Tiopronin Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Tiopronin Revenue Market Share by Application (2019-2024)
Table 30. Global Tiopronin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Tiopronin Revenue Market Share by Application (2025-2030)
Table 32. North America Tiopronin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Tiopronin Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Tiopronin Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Tiopronin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Tiopronin Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Tiopronin Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Tiopronin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Tiopronin Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Tiopronin Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Tiopronin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Tiopronin Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Tiopronin Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Tiopronin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Tiopronin Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Tiopronin Market Size by Country (2025-2030) & (US$ Million)
Table 47. Henan Xinyi Pharmaceutical Group Company Detail
Table 48. Henan Xinyi Pharmaceutical Group Business Overview
Table 49. Henan Xinyi Pharmaceutical Group Tiopronin Product
Table 50. Henan Xinyi Pharmaceutical Group Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 51. Henan Xinyi Pharmaceutical Group Recent Development
Table 52. Changzhou Yabang Pharmaceutical Co. Ltd Company Detail
Table 53. Changzhou Yabang Pharmaceutical Co. Ltd Business Overview
Table 54. Changzhou Yabang Pharmaceutical Co. Ltd Tiopronin Product
Table 55. Changzhou Yabang Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 56. Changzhou Yabang Pharmaceutical Co. Ltd Recent Development
Table 57. Jiangsu Desano Pharmaceutical Co. Ltd Company Detail
Table 58. Jiangsu Desano Pharmaceutical Co. Ltd Business Overview
Table 59. Jiangsu Desano Pharmaceutical Co. Ltd Tiopronin Product
Table 60. Jiangsu Desano Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 61. Jiangsu Desano Pharmaceutical Co. Ltd Recent Development
Table 62. Hangzhou Minsheng Pharmaceutical Co. Ltd Company Detail
Table 63. Hangzhou Minsheng Pharmaceutical Co. Ltd Business Overview
Table 64. Hangzhou Minsheng Pharmaceutical Co. Ltd Tiopronin Product
Table 65. Hangzhou Minsheng Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 66. Hangzhou Minsheng Pharmaceutical Co. Ltd Recent Development
Table 67. Wuhan Yuanda Pharmaceutical Group Company Detail
Table 68. Wuhan Yuanda Pharmaceutical Group Business Overview
Table 69. Wuhan Yuanda Pharmaceutical Group Tiopronin Product
Table 70. Wuhan Yuanda Pharmaceutical Group Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 71. Wuhan Yuanda Pharmaceutical Group Recent Development
Table 72. Shanghai Kaibao Pharmaceutical Co., Ltd. Company Detail
Table 73. Shanghai Kaibao Pharmaceutical Co., Ltd. Business Overview
Table 74. Shanghai Kaibao Pharmaceutical Co., Ltd. Tiopronin Product
Table 75. Shanghai Kaibao Pharmaceutical Co., Ltd. Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 76. Shanghai Kaibao Pharmaceutical Co., Ltd. Recent Development
Table 77. Sinopharm Guorui Pharmaceutical Co. Ltd Company Detail
Table 78. Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
Table 79. Sinopharm Guorui Pharmaceutical Co. Ltd Tiopronin Product
Table 80. Sinopharm Guorui Pharmaceutical Co. Ltd Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 81. Sinopharm Guorui Pharmaceutical Co. Ltd Recent Development
Table 82. AdvaCare Company Detail
Table 83. AdvaCare Business Overview
Table 84. AdvaCare Tiopronin Product
Table 85. AdvaCare Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 86. AdvaCare Recent Development
Table 87. Clinigen Direct Company Detail
Table 88. Clinigen Direct Business Overview
Table 89. Clinigen Direct Tiopronin Product
Table 90. Clinigen Direct Revenue in Tiopronin Business (2019-2024) & (US$ Million)
Table 91. Clinigen Direct Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tiopronin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tiopronin Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Tablet Features
Figure 5. Capsule Features
Figure 6. Global Tiopronin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tiopronin Market Share by Application: 2023 VS 2030
Figure 8. Fatty liver Disease Case Studies
Figure 9. Early Senile Cataract Case Studies
Figure 10. Eczema Case Studies
Figure 11. Tiopronin Report Years Considered
Figure 12. Global Tiopronin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Tiopronin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Tiopronin Market Share by Region: 2023 VS 2030
Figure 15. Global Tiopronin Market Share by Players in 2023
Figure 16. Global Top Tiopronin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tiopronin as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Tiopronin Revenue in 2023
Figure 18. North America Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Tiopronin Market Share by Country (2019-2030)
Figure 20. United States Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Tiopronin Market Share by Country (2019-2030)
Figure 24. Germany Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Tiopronin Market Share by Region (2019-2030)
Figure 32. China Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Tiopronin Market Share by Country (2019-2030)
Figure 40. Mexico Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Tiopronin Market Share by Country (2019-2030)
Figure 44. Turkey Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Tiopronin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Henan Xinyi Pharmaceutical Group Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 47. Changzhou Yabang Pharmaceutical Co. Ltd Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 48. Jiangsu Desano Pharmaceutical Co. Ltd Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 49. Hangzhou Minsheng Pharmaceutical Co. Ltd Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 50. Wuhan Yuanda Pharmaceutical Group Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 51. Shanghai Kaibao Pharmaceutical Co., Ltd. Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 52. Sinopharm Guorui Pharmaceutical Co. Ltd Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 53. AdvaCare Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 54. Clinigen Direct Revenue Growth Rate in Tiopronin Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
